1. Merck’s HIV drug Isentress is now available as a higher-dose, once-daily formula.
2. Rebinyn is intended to treat adults and children with hemophilia B, an inherited blood disorder that causes prolonged or spontaneous bleeding.
3. Atomoxetine is a generic version of Eli Lilly’s attention-deficit/hyperactivity disorder drug, Strattera.
4. Zykadia may now be used as a first-line treatment for patients with metastatic non-small cell lung cancer whose tumors carry a specific enzyme identified through an FDA-approved test.
5. Nebivolol represents the first generic version of the hypertension drug Bystolic.
More articles on supply chain:
FDA OKs higher dose of Merck’s HIV drug
DHL exec: 3 tech solutions innovating healthcare supply chain
Exact Sciences stock jumps 12% after UnitedHealth issues positive coverage for Cologuard
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
